BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Cisplatin
,
rs3825942
,
FOXP1
,
Fatty acid metabolic process
,
Lung cancer
,
Lymphocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
blinatumomab
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Blinatumomab in Practice.
Blinatumomab Conundrum in Low-Risk Relapsed B-Cell ALL.
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL.
Reduced-dose chemotherapy followed by blinatumomab in induction therapy for newly diagnosed B-cell a…
Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic he…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Blinatumomab Bridging Therapy
Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation
Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab
Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Old…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ